Sodium-Glucose Co-transporter-2 Inhibitors and Nephroprotection in Diabetic Patients: More Than a Challenge.
Front Med (Lausanne). 2021 Jun 4;8:654557. doi: 10.3389/fmed.2021.654557. eCollection 2021.
Front Med (Lausanne). 2021.
PMID: 34150796
Free PMC article.
Review.